Skip to main content

STIFEL FINANCIAL CORP

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 720672 ST. LOUIS, MO

Position in IOVA

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$1,578,232
+$677,839 QoQ
Shares Held
449,639
+36.3% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 99.93194540509164.ToString("F0")% Shared 0.ToString("F0")% None 0.06805459490835981.ToString("F0")%

Common Shares in IOVA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

STIFEL FINANCIAL CORP holds $433,142,280 across 103 Biotechnology names. IOVA ranks #35 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IOVA

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,578,232 449,639
2025-12-31 $900,393 329,815
2025-09-30 $758,620 349,595
2025-06-30 $388,100 225,640
2025-03-31 $548,863 164,824
2024-12-31 $1,553,992 209,999
2024-09-30 $2,094,973 223,107
2024-06-30 $1,317,845 164,320
2024-03-31 $3,827,931 258,295
2023-12-31 $2,510,170 308,754
2023-09-30 $1,047,200 230,154
2023-06-30 $2,297,384 326,333
2023-03-31 $909,736 148,893
2022-12-31 $881,340 137,925
2021-09-30 $215,404 8,735
2021-06-30 $223,771 8,600
2021-03-31 $864,380 27,302
2020-12-31 $1,494,914 32,218
2020-09-30 $1,029,637 31,277
2020-06-30 $829,730 30,227
2020-03-31 $970,354 32,410